| Issue Date | Title | Author(s) |
| 2018-01-01 | Role of oxidative stress in the pathology and management of human tuberculosis | Shastri, MD; Shukla, SD; Chong, WC; Dua, K; Peterson, GM; Patel, RP; Hansbro, PM; Eri, R; O'Toole, RF |
| 2018-11-01 | Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches | Dua, K; Rapalli, VK; Shukla, SD; Singhvi, G; Shastri, MD; Chellappan, DK; Satija, S; Mehta, M; Gulati, M; Pinto, TDJA; Gupta, G; Hansbro, PM |
| 2015-09-01 | Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15 | Hare, NJ; Chan, B; Chan, E; Kaufman, KL; Britton, WJ; Saunders, BM |
| 2021-12-09 | Synthetic Sansanmycin Analogues as Potent Mycobacterium tuberculosis Translocase I Inhibitors. | Tran, W; Kusay, AS; Hawkins, PME; Cheung, C-Y; Nagalingam, G; Pujari, V; Ford, DJ; Stoye, A; Ochoa, JL; Audette, RE; Hortle, E; Oehlers, SH; Charman, SA; Linington, RG; Rubin, EJ; Dowson, CG; Roper, DI; Crick, DC; Balle, T; Cook, GM; Britton, WJ; Payne, RJ |
| 2018-11 | Mycobacterium marinum infection drives foam cell differentiation in zebrafish infection models. | Johansen, MD; Kasparian, JA; Hortle, E; Britton, WJ; Purdie, AC; Oehlers, SH |
| 2021-11 | Macrophages of different tissue origin exhibit distinct inflammatory responses to mycobacterial infection. | Stevens, MT; Nagaria, BD; Britton, WJ; Saunders, BM |
| 2022-08 | The ESX-4 substrates, EsxU and EsxT, modulate Mycobacterium abscessus fitness. | Lagune, M; Le Moigne, V; Johansen, MD; Vásquez Sotomayor, F; Daher, W; Petit, C; Cosentino, G; Paulowski, L; Gutsmann, T; Wilmanns, M; Maurer, FP; Herrmann, J-L; Girard-Misguich, F; Kremer, L |
| 2022 | 1H-1,2,3-triazole embedded Isatin-Benzaldehyde-bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation. | Sharma, B; Kumar, S; Preeti,; Johansen, MD; Kremer, L; Kumar, V |
| 2019-05-01 | The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets. | Black, HD; Xu, W; Hortle, E; Robertson, SI; Britton, WJ; Kaur, A; New, EJ; Witting, PK; Chami, B; Oehlers, SH |
| 2017-01-06 | Mycobacterium tuberculosis Infection Manipulates the Glycosylation Machinery and the N-Glycoproteome of Human Macrophages and Their Microparticles | Hare, NJ; Lee, LY; Loke, I; Britton, WJ; Saunders, BM; Thaysen-Andersen, M |
